Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and ...

Omada Health, a 14-year-old digital health company supporting chronic disease patients, has yet to generate profits.

RFK Jr.'s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this ...

President Trump's 2026 budget proposes cutting NIH grants to universities, academic medical centers, and other institutions ...

The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.

A large government study published Thursday shows more definitively than ever before that Americans’ self-reported race is a ...

It looks like the NIH is thinking about AI differently than the FDA, who earlier this week released a “rushed” AI tool across ...

HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

An Otsuka drug succeeded in a Phase 3 study in a chronic kidney disease, with results that outperformed a competitor's recent ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

From STAT’s Adam Feuerstein: Another example of why biotech is a tough business.